Ibrahim Swaray

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20

Ronald Carshon-Marsh, Ashley Aimone, Rashid Ansumana et al. · The Lancet Global Health · 2021 · 73 citations · Full text

Public Health, Child Health, Population Health Sciences +14

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi et al. · The Lancet Global Health · 2023 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children

David Ishola, Osman Bah, Foday Suma Bangalie et al. · Clinical Infectious Diseases · 2022 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17